Table 2 Baseline characteristics between two groups (post-op)
Variables | Group P (n = 100) | Group D (n = 108) | P |
|---|---|---|---|
Pathological cancer stage | 0.582 | ||
IA1 | 20 | 13 | |
IA2 | 34 | 43 | |
IA3 | 23 | 24 | |
IB | 5 | 9 | |
IIA | 1 | 1 | |
IIB | 4 | 4 | |
IIIA | 10 | 7 | |
Unstaged | 3 | 7 | |
Histological diagnosis | 0.801 | ||
Squamous cell carcinoma | 2 | 2 | |
Adenocarcinoma | 90 | 95 | |
Mucinous adenocarcinoma | 3 | 4 | |
Adenosquamous carcinoma | 1 | 1 | |
Benign nodule | 1 | 1 | |
Sclerosing pneumocytoma | 0 | 1 | |
Lymphoepithelioma-like carcinoma | 1 | 0 | |
Lymphoma | 0 | 2 | |
Mucoepidermoid carcinoma | 0 | 1 | |
Myoepithelial carcinoma | 0 | 1 | |
Pleomorphic carcinoma | 2 | 0 | |